COMPANY INFO
IQVIA Holdings, Inc., founded in 1982 by Dennis Gillings, is a leading global provider in the contract research organization and pharmaceutical services industry. With approximately 88,000 employees as of 2024, IQVIA operates worldwide from its headquarters in Durham, North Carolina, offering advanced analytics, technology solutions, and clinical research services to the life sciences sector through its website iqvia.com. The company specializes in health information technology, clinical trial management, and commercial outsourcing services, enabling faster drug development and improved healthcare outcomes globally.
IQVIA Holdings, Inc. is a global leader in contract research, pharmaceutical services, analytics, and health information technology. The company, founded in 1982 by Dennis Gillings, employs nearly 88,000 people, providing AI-driven solutions and clinical research expertise to life sciences companies worldwide.
IQVIA Holdings, Inc. is guided by a seasoned executive management team whose collective experience spans pharmaceuticals, technology, finance, and global operations. The leadership is recognized for its robust expertise in integrating advanced analytics, developing digital health solutions, and managing large-scale organizational growth—driving innovation and value creation for clients and stakeholders globally. The IQVIA CEO and management team are at the forefront of industry advancements, propelling the company’s continued success.
As CEO since October 2016, Ari Bousbib has led IQVIA Holdings, Inc. through transformative integration following its major merger, spearheading the development of IQVIA Connected Intelligence™ and expanding global analytics and clinical research services. Under his guidance, the company experienced significant innovation acceleration and revenue growth, further establishing the strategic direction for IQVIA leadership in health data and solutions.
Ari Bousbib’s prior roles include CEO of IMS Health, COO and CEO at Otis Elevator under United Technologies, and partner at Booz Allen Hamilton. He also serves on The Home Depot board and the Harvard Medical School advisory council. He holds a B.A. from the University of Pennsylvania and an M.B.A. from Harvard Business School, underscoring a career built at the intersection of healthcare, technology, and management.
Ron Bruehlman, as Executive Vice President and CFO since August 2020, oversees finances, treasury, tax, corporate development, and audit at IQVIA Holdings, Inc. He played a pivotal role in optimizing post-IPO capital structure and managing debt, enhancing the company’s fiscal resilience and supporting IQVIA’s rapid global expansion.
Bruehlman’s 40-year career spans top financial leadership at IMS Health, senior executive roles at United Technologies, and early experience at ConocoPhillips. He serves on the GoodRX board and holds a B.S. in Economics from the University of Delaware and an M.B.A. from Chicago Booth, bringing deep financial and strategic expertise to the IQVIA management team.
Trudy Stein leads IQVIA Holdings, Inc.'s global Human Resources as Executive Vice President and CHRO, championing initiatives in diversity, talent acquisition, and organizational development. Her leadership enhanced employee engagement by 20% and established robust workforce development programs across the company’s 86,000 employees worldwide.
She brings high-level HR experience from previous CHRO roles at Fortune 500 firms and was instrumental in global HR leadership at IMS Health before the merger. Trudy holds an M.S. in Organizational Psychology from Cornell University and a B.A. from the University of California, Berkeley.
Bernd Haas steers IQVIA Holdings, Inc.'s digital product and innovation strategy, directing the successful launch of the Human Data Science Cloud and advanced analytics platforms. His efforts drove a 35% increase in digital revenues and helped solidify IQVIA’s reputation as a pioneer in digital transformation within life sciences.
With 25 years at the intersection of digital health and software, Bernd holds a Ph.D. in Computer Science from ETH Zurich and a B.Sc. from the Technical University of Munich, reflecting his in-depth technical expertise and visionary approach to product leadership.
Eric Sherbet, Executive Vice President and General Counsel, manages all global legal, compliance, and privacy affairs at IQVIA Holdings, Inc. He successfully guided the company through GDPR implementation and multiple major acquisitions, notably reducing IQVIA’s legal risk exposure by 30%.
Previously General Counsel at Patheon and InVentiv Health, Eric began his career as a CPA at KPMG. He holds a J.D. from NYU School of Law and a B.Comm. in Accounting from the University of Virginia, exemplifying the broad legal and business acumen present in the IQVIA executives team.
Leading global CRO operations, Richard Staub steered IQVIA Holdings, Inc. through the COVID-19 era by expanding clinical trial capabilities and securing $1.2B in pandemic-related contracts. His leadership accelerated patient recruitment by 40%, strengthening IQVIA’s market position.
With 34 years in life sciences, including serving as president of Novella Clinical, Richard brings extensive clinical development knowledge. He earned his B.A. in Economics from the University of North Carolina at Chapel Hill, building a distinguished career driving R&D solutions.
Bhavik Patel leads the commercial analytics and technology arm of IQVIA Holdings, Inc., introducing AI-driven forecasting tools now adopted by 70% of the top 25 pharmaceutical companies. His innovations have boosted client ROI by 25%, shaping commercial strategies and sustaining IQVIA’s industry leadership.
With 20 years in pharma analytics and commercial solutions, Bhavik holds an M.B.A. from INSEAD and a B.Eng. from the Indian Institute of Technology Bombay, showcasing expertise that anchors the IQVIA management team.
Rob Kotchie oversees real-world evidence (RWE) solutions at IQVIA Holdings, Inc., where he developed new frameworks that generated $500M in business and improved regulatory submission success rates by 30%. These contributions strengthen IQVIA’s position as a leader in RWE and regulatory science.
With 15 years in pharmacoepidemiology, Rob holds an M.S. in Epidemiology from Johns Hopkins University and a B.S. in Biology from the University of Toronto, reflecting depth in scientific research and analytics.
As Chief Medical and Scientific Officer, Jeffrey Spaeder, M.D., guides medical strategy and scientific innovation at IQVIA Holdings, Inc., pioneering decentralized and patient-centric clinical trials. His leadership has cut trial timelines by 20% and improved data quality for the company’s clinical research activities.
A graduate of Harvard Medical School (M.D.) and Yale University (B.A. in Biology), Jeffrey is a former CMO at major CROs and brings a wealth of scientific, clinical, and executive experience to the IQVIA executive team.
Cynthia Verst drives R&D solution innovation at IQVIA Holdings, Inc., launching design thinking labs and digital delivery models that increased client satisfaction by 25% and cut program launch times by 15%. Her initiatives have modernized and streamlined the company’s delivery framework.
With 20 years in clinical operations, an M.B.A. from Wharton, and a B.S. in Biomedical Engineering from Duke University, Cynthia’s career is marked by a focus on operational excellence and patient-centered delivery.
IQVIA Holdings, Inc. benefits from a diverse, high-caliber leadership team with backgrounds in global pharmaceutical services, advanced analytics, digital health, finance, and legal operations. The company structure features functional and business unit presidents reporting to the CEO, supported by expert leaders in finance, HR, and digital product development. Collectively, the IQVIA executives and management team promote innovation, operational integrity, and strategic growth to keep the company at the forefront of life sciences advancement. As industry pioneers, the IQVIA founders and their successors set high standards for the organization’s ongoing leadership.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the IQVIA Holdings, Inc. leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.